KERRI OUTLAW: Open Payments
NPI 1740821958 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 22 payments from 8 companies in 2025. Trend: 2023 $659 · 2024 $2,239 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $92 |
| Neurocrine BioSciences, Inc. | 2 | $84 |
| Otsuka America Pharmaceutical, Inc. | 1 | $74 |
| Corium, LLC | 7 | $70 |
| Tris Pharma Inc | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $16 |
Products named: FANAPT, CAPLYTA, INGREZZA, REXULTI, Azstarys, Dyanavel XR, TRINTELLIX, EkoSonic.
Industry payments across AL — which companies pay providers there.
